Strongest evidence
Three outcomes carry moderate evidence strength. For reduced AST (5 studies), 3 of 5 showed small beneficial effects in NAFLD/NASH/MASLD patients, with doses 300–1000 IU/day. For reduced ALT (4 studies), all 4 reported beneficial effects in NAFLD (3 significant), dose 400–1000 IU/day. For reduced pain (3 studies), all three reported small beneficial effects in fibromyalgia, carpal tunnel, and oral mucosal diseases, often combined with other nutrients. Caveats include possible publication bias and small study sizes.
Mixed or weaker evidence
Five outcomes have low evidence strength. Reduced malondialdehyde (1 beneficial of 3) showed a large effect in epilepsy patients, but two neutral studies limit confidence. Reduced TNF-α (1 beneficial of 3) showed a small reduction in NASH patients with 400 IU twice daily, but no effect in hemodialysis or sarcopenic women. Reduced vitamin E level (1 beneficial of 3) found an association between lower vitamin E and vitiligo, but does not support supplementation. Reduced inflammation (3 of 3 beneficial) had mixed effect sizes (small to large) across GI surgery, sarcopenia, and NAFLD populations, dose 335 mg/day. Improved sperm morphology (1 beneficial of 3) showed moderate effect in asthenozoospermia/teratozoospermia with 300 mg/day, but two studies neutral.
Effective dose patterns
Liver outcomes converge on 300–1000 IU/day (AST) and 400–1000 IU/day (ALT). Inflammation outcomes used 335 mg/day (approximately 500 IU). Pain studies did not report a clear effective dose. Sperm morphology had one study using 300 mg/day.
Population insights
The most studied populations are patients with NAFLD/NASH/MASLD (for liver enzymes) and chronic pain conditions (fibromyalgia, carpal tunnel). Other populations include epilepsy, hemodialysis, sarcopenic older women, and men with infertility. Effects are not well-established in healthy individuals.
Notable caveats
- Publication bias is flagged for many outcomes — overwhelmingly positive results may overestimate effects.
- Most evidence bases are small (3–5 studies), making conclusions preliminary.
- Some studies used vitamin E alongside other supplements, making it difficult to isolate its effect.
- Many individual studies did not reach statistical significance, suggesting true effect sizes may be smaller than observed.